LNMG OTC
Linike Medical Group Ltd
1W: -40.0%
1M: +2.0%
3M: -3.8%
YTD: -86.9%
1Y: -66.0%
3Y: -99.9%
5Y: -99.9%
$0.01
-0.00 (-40.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$767K
+66.0% ▲
Capital Expenditures
$228K
-288.0% ▼
Free Cash Flow
-$995K
+57.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$0
-100.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$89K | -$30K | -$66K | $991K | -$245K |
| Depreciation & Amort. | $0 | $0 | $0 | $65K | $55K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$2K | $8K | $8K | -$3M | -$577K |
| Other Non-Cash Items | $70K | $0 | $39K | $0 | $0 |
| Operating Cash Flow | -$21K | -$22K | -$19K | -$2M | -$767K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | -$59K | -$228K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$59K | -$228K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $620K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $21K | $23K | $19K | $2M | $0 |
| Financing Cash Flow | $21K | $23K | $19K | $2M | $620K |
| Net Change in Cash | -$91 | $1K | $270 | $788K | $0 |
| Cash End of Period | -$91 | $1K | $1K | $789K | $688K |
| Free Cash Flow | -$21K | -$22K | -$19K | -$2M | -$995K |